Daily Oral PCSK9 Inhibitor Encouraging in Phase 1 Trials Daily Oral PCSK9 Inhibitor Encouraging in Phase 1 Trials

What if the cholesterol-crushing efficacy of current PCSK9 inhibitors came in a pill instead of a syringe? That ' s one possibility for a Merck agent in the earliest stages of human trials.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news